Cargando…

Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis

A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and so...

Descripción completa

Detalles Bibliográficos
Autores principales: Fino, Edita, Russo, Paolo Maria, Tengattini, Vera, Bardazzi, Federico, Patrizi, Annalisa, Martoni, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624212/
https://www.ncbi.nlm.nih.gov/pubmed/34834589
http://dx.doi.org/10.3390/jpm11111236
_version_ 1784606118601818112
author Fino, Edita
Russo, Paolo Maria
Tengattini, Vera
Bardazzi, Federico
Patrizi, Annalisa
Martoni, Monica
author_facet Fino, Edita
Russo, Paolo Maria
Tengattini, Vera
Bardazzi, Federico
Patrizi, Annalisa
Martoni, Monica
author_sort Fino, Edita
collection PubMed
description A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis.
format Online
Article
Text
id pubmed-8624212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86242122021-11-27 Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis Fino, Edita Russo, Paolo Maria Tengattini, Vera Bardazzi, Federico Patrizi, Annalisa Martoni, Monica J Pers Med Article A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis. MDPI 2021-11-21 /pmc/articles/PMC8624212/ /pubmed/34834589 http://dx.doi.org/10.3390/jpm11111236 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fino, Edita
Russo, Paolo Maria
Tengattini, Vera
Bardazzi, Federico
Patrizi, Annalisa
Martoni, Monica
Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_full Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_fullStr Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_full_unstemmed Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_short Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_sort individual differences in emotion dysregulation and social anxiety discriminate between high vs. low quality of life in patients with mild psoriasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624212/
https://www.ncbi.nlm.nih.gov/pubmed/34834589
http://dx.doi.org/10.3390/jpm11111236
work_keys_str_mv AT finoedita individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT russopaolomaria individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT tengattinivera individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT bardazzifederico individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT patriziannalisa individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT martonimonica individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis